CD274 and non-small cell lung carcinoma: This study provides important context regarding the experience of the resected, early-stage PD-L1+ NSCLC population, and emphasizes the need for access to neoadjuvant, adjuvant, and perioperative regimens that can potentially improve patient outcomes.